MIIM
TWNK

Mesirow Institutional Investment Management’s Hostess Brands, Inc. Class A Common Stock TWNK Stock Holding History

Mesirow Institutional Investment Management’s Portfolio TWNK Stock Details TWNK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-243,788
Closed -$8.12M – 138
2023
Q3 		$8.12M Sell
243,788
-180,997
-43% -$4.85M 0.82% 72
2023
Q2 		$10.8M Buy
424,785
+323,313
+319% +$8.29M 1.11% 47
2023
Q1 		$2.52M Buy
+101,472
New +$2.39M 0.27% 113

Other funds holding TWNK

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mesirow Institutional Investment Management's TWNK Position: Q4 2023 in Review

Mesirow Institutional Investment Management sold out of Hostess Brands, Inc. Class A Common Stock (TWNK) in Q4 2023, closing a stake of 243,788 shares — an estimated $8.12M sold.

Mesirow Institutional Investment Management first reported a position in TWNK in Q1 2023 and held it in 3 quarters. The position peaked at $10.8M in Q2 2023. 3 funds tracked by Wall St. Rank hold TWNK as of Q4 2023.

  • Mesirow Institutional Investment Management reported no remaining Hostess Brands, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mesirow Institutional Investment Management sold 243,788 Hostess Brands, Inc. Class A Common Stock shares in Q4 2023, an estimated $8.12M.
  • Mesirow Institutional Investment Management first reported a position in Hostess Brands, Inc. Class A Common Stock in Q1 2023 and held it in 3 quarters.
  • Mesirow Institutional Investment Management's Hostess Brands, Inc. Class A Common Stock position peaked at $10.8M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Hostess Brands, Inc. Class A Common Stock as of Q4 2023.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.